Literature DB >> 6342543

Failure of intrathecal antitetanus serum to improve survival in neonatal tetanus.

J Neequaye, F K Nkrumah.   

Abstract

In a prospective study, 161 infants with neonatal tetanus were randomised to receive (a) standard treatment, or (b) standard treatment together with intrathecal equine antitetanus serum, or (c) intrathecal antitetanus serum with systemic betamethasone. There was no difference in survival between the three treatment groups in infants with severe tetanus, but in mild tetanus those who received standard treatment alone had an improved survival rate. Parenteral intramuscular diazepam as a sedative was found to be preferable to paraldehyde, as the latter was associated with a higher incidence of secondary infections.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6342543      PMCID: PMC1627953          DOI: 10.1136/adc.58.4.276

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  8 in total

1.  Treatment of tetanus neonatorum with muscle relaxants and intermittent positive-pressure ventilation.

Authors:  P M Smythe; M D Bowie; T J Voss
Journal:  Br Med J       Date:  1974-02-09

2.  Tetanus.

Authors:  I Ildirim; A R Meira; M L Furcolow
Journal:  N Engl J Med       Date:  1969-05-29       Impact factor: 91.245

3.  The treatment of tetanus with special reference to betamethasone.

Authors:  R K Sanders; T N Strong; M L Peacock
Journal:  Trans R Soc Trop Med Hyg       Date:  1969       Impact factor: 2.184

4.  Intrathecal antitetanus serum (horse) in the treatment of tetanus.

Authors:  R K Sanders; B Martyn; R Joseph; M L Peacock
Journal:  Lancet       Date:  1977-05-07       Impact factor: 79.321

5.  Intrathecal tetanus antitoxin in moderate and severe tetanus.

Authors:  N K Keswani; A K Singh; K D Upadhyaya
Journal:  J Indian Med Assoc       Date:  1980-08-16

6.  Intrathecal antitetanus serum (horse) with steroid in the treatment of neonatal tetanus.

Authors:  A K Singh; A Bansal; S P Goel; V K Agarwal
Journal:  Arch Dis Child       Date:  1980-07       Impact factor: 3.791

7.  Therapeutic trial of intracisternal human tetanus immunoglobulin in clinical tetanus.

Authors:  B J Vakil; P Armitage; R E Clifford; D R Laurence
Journal:  Trans R Soc Trop Med Hyg       Date:  1979       Impact factor: 2.184

8.  Intrathecal human tetanus immunoglobulin in early tetanus.

Authors:  P S Gupta; R Kapoor; S Goyal; V K Batra; B K Jain
Journal:  Lancet       Date:  1980-08-30       Impact factor: 79.321

  8 in total
  1 in total

1.  Human versus equine intramuscular antitoxin, with or without human intrathecal antitoxin, for the treatment of adults with tetanus: a 2 × 2 factorial randomised controlled trial.

Authors:  Nguyen Van Hao; Huynh Thi Loan; Lam Minh Yen; Evelyne Kestelyn; Duc Du Hong; Duong Bich Thuy; Nguyen Thanh Nguyen; Ha Thi Hai Duong; Tran Thi Diem Thuy; Phung Tran Huy Nhat; Phan Nguyen Quoc Khanh; Nguyen Thi Phuong Dung; Nguyen Hoan Phu; Nguyen Thanh Phong; Pham Thi Lieu; Pham Thi Tuyen; Bui Thi Bich Hanh; Ho Dang Trung Nghia; Pham Kieu Nguyet Oanh; Phan Vinh Tho; Tran Tan Thanh; Hugo C Turner; H Rogier van Doorn; Le Van Tan; Duncan Wyncoll; Nicholas Pj Day; Ronald B Geskus; Guy E Thwaites; Nguyen Van Vinh Chau; C Louise Thwaites
Journal:  Lancet Glob Health       Date:  2022-06       Impact factor: 38.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.